Escitalopram Market Report

Global and Region Escitalopram Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：181
  • REPORT CODE：GMM909303
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Escitalopram market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Escitaloprammarket, defines the market attractiveness level of Escitalopram market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Escitalopram industry, describes the types of Escitalopram market, the applications of major players and the market size, and deeply analyzes the current situation of the global Escitalopram market and the development prospects and opportunities of Escitalopram industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Escitalopram market in Chapter 13.

    By Player:

    • Macleods Pharmaceuticals(IN)

    • Lupin Limited(IN)

    • Aurobindo Pharma(IN)

    • Amneal Pharmaceuticals(US)

    • STI Pharma(US)

    • Hetero Drugs(IN)

    • Apotex(CA)

    • Jubilant Pharma(SG)

    • HLundbeck A/S(DK)

    • Silarx Pharmacueticals(US)

    • Prinston Pharmaceutical(US)

    • TEVA Pharmaceutical(US)

    • Hikma Pharmaceuticals(UK)

    • Forest Laboratories(US)

    By Type:

    • Solution

    • Tablet

    • Others

    By End-User:

    • Hospitals and Clinics

    • Individual Use

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Escitalopram Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Escitalopram Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Escitalopram Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Escitalopram Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Escitalopram Market Analysis and Outlook to 2022

    • 7.1 Global Escitalopram Consumption (2017-2022)

    • 7.2 United States Escitalopram Consumption (2017-2022)

    • 7.3 Europe Escitalopram Consumption (2017-2022)

    • 7.4 China Escitalopram Consumption (2017-2022)

    • 7.5 Japan Escitalopram Consumption (2017-2022)

    • 7.6 India Escitalopram Consumption (2017-2022)

    • 7.7 South Korea Escitalopram Consumption (2017-2022)

    8 Region and Country-wise Escitalopram Market Analysis and Outlook to 2028

    • 8.1 Global Escitalopram Consumption Forecast (2022-2028)

    • 8.2 United States Escitalopram Consumption Forecast (2022-2028)

    • 8.3 Europe Escitalopram Consumption Forecast (2022-2028)

    • 8.4 China Escitalopram Consumption Forecast (2022-2028)

    • 8.5 Japan Escitalopram Consumption Forecast (2022-2028)

    • 8.6 India Escitalopram Consumption Forecast (2022-2028)

    • 8.7 South Korea Escitalopram Consumption Forecast (2022-2028)

    9 Global Escitalopram Market Outlook by Types and Applications to 2022

    • 9.1 Global Escitalopram Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Solution Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Tablet Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Escitalopram Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Individual Use Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Escitalopram Market Outlook by Types and Applications to 2028

    • 10.1 Global Escitalopram Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Solution Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Tablet Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Escitalopram Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Individual Use Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Escitalopram Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Escitalopram Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Escitalopram Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Escitalopram Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Escitalopram Market Competitive Analysis

    • 14.1 Macleods Pharmaceuticals(IN)

      • 14.1.1 Macleods Pharmaceuticals(IN) Company Details

      • 14.1.2 Macleods Pharmaceuticals(IN) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Macleods Pharmaceuticals(IN) Escitalopram Product and Service

    • 14.2 Lupin Limited(IN)

      • 14.2.1 Lupin Limited(IN) Company Details

      • 14.2.2 Lupin Limited(IN) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Lupin Limited(IN) Escitalopram Product and Service

    • 14.3 Aurobindo Pharma(IN)

      • 14.3.1 Aurobindo Pharma(IN) Company Details

      • 14.3.2 Aurobindo Pharma(IN) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Aurobindo Pharma(IN) Escitalopram Product and Service

    • 14.4 Amneal Pharmaceuticals(US)

      • 14.4.1 Amneal Pharmaceuticals(US) Company Details

      • 14.4.2 Amneal Pharmaceuticals(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Amneal Pharmaceuticals(US) Escitalopram Product and Service

    • 14.5 STI Pharma(US)

      • 14.5.1 STI Pharma(US) Company Details

      • 14.5.2 STI Pharma(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 STI Pharma(US) Escitalopram Product and Service

    • 14.6 Hetero Drugs(IN)

      • 14.6.1 Hetero Drugs(IN) Company Details

      • 14.6.2 Hetero Drugs(IN) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Hetero Drugs(IN) Escitalopram Product and Service

    • 14.7 Apotex(CA)

      • 14.7.1 Apotex(CA) Company Details

      • 14.7.2 Apotex(CA) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Apotex(CA) Escitalopram Product and Service

    • 14.8 Jubilant Pharma(SG)

      • 14.8.1 Jubilant Pharma(SG) Company Details

      • 14.8.2 Jubilant Pharma(SG) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Jubilant Pharma(SG) Escitalopram Product and Service

    • 14.9 HLundbeck A/S(DK)

      • 14.9.1 HLundbeck A/S(DK) Company Details

      • 14.9.2 HLundbeck A/S(DK) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 HLundbeck A/S(DK) Escitalopram Product and Service

    • 14.10 Silarx Pharmacueticals(US)

      • 14.10.1 Silarx Pharmacueticals(US) Company Details

      • 14.10.2 Silarx Pharmacueticals(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Silarx Pharmacueticals(US) Escitalopram Product and Service

    • 14.11 Prinston Pharmaceutical(US)

      • 14.11.1 Prinston Pharmaceutical(US) Company Details

      • 14.11.2 Prinston Pharmaceutical(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Prinston Pharmaceutical(US) Escitalopram Product and Service

    • 14.12 TEVA Pharmaceutical(US)

      • 14.12.1 TEVA Pharmaceutical(US) Company Details

      • 14.12.2 TEVA Pharmaceutical(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 TEVA Pharmaceutical(US) Escitalopram Product and Service

    • 14.13 Hikma Pharmaceuticals(UK)

      • 14.13.1 Hikma Pharmaceuticals(UK) Company Details

      • 14.13.2 Hikma Pharmaceuticals(UK) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Hikma Pharmaceuticals(UK) Escitalopram Product and Service

    • 14.14 Forest Laboratories(US)

      • 14.14.1 Forest Laboratories(US) Company Details

      • 14.14.2 Forest Laboratories(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Forest Laboratories(US) Escitalopram Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Escitalopram

    • Figure Escitalopram Picture

    • Table Global Escitalopram Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Escitalopram Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Escitalopram Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Escitalopram Consumption by Country (2017-2022)

    • Figure United States Escitalopram Consumption and Growth Rate (2017-2022)

    • Table Europe Escitalopram Consumption and Growth Rate (2017-2022)

    • Figure China Escitalopram Consumption and Growth Rate (2017-2022)

    • Figure Japan Escitalopram Consumption and Growth Rate (2017-2022)

    • Figure India Escitalopram Consumption and Growth Rate (2017-2022)

    • Figure South Korea Escitalopram Consumption and Growth Rate (2017-2022)

    • Figure Global Escitalopram Consumption Forecast by Country (2022-2028)

    • Figure United States Escitalopram Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Escitalopram Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Escitalopram Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Escitalopram Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Escitalopram Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Escitalopram Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Solution Consumption and Growth Rate (2017-2022)

    • Figure Global Tablet Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Individual Use Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Solution Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Individual Use Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Escitalopram Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Escitalopram Export by Region (Top 5 Countries) (2017-2028)

    • Table Macleods Pharmaceuticals(IN) (Foundation Year, Company Profile and etc.)

    • Table Macleods Pharmaceuticals(IN) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table Macleods Pharmaceuticals(IN) Escitalopram Product and Service

    • Table Lupin Limited(IN) (Foundation Year, Company Profile and etc.)

    • Table Lupin Limited(IN) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lupin Limited(IN) Escitalopram Product and Service

    • Table Aurobindo Pharma(IN) (Foundation Year, Company Profile and etc.)

    • Table Aurobindo Pharma(IN) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Pharma(IN) Escitalopram Product and Service

    • Table Amneal Pharmaceuticals(US) (Foundation Year, Company Profile and etc.)

    • Table Amneal Pharmaceuticals(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amneal Pharmaceuticals(US) Escitalopram Product and Service

    • Table STI Pharma(US) (Foundation Year, Company Profile and etc.)

    • Table STI Pharma(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table STI Pharma(US) Escitalopram Product and Service

    • Table Hetero Drugs(IN) (Foundation Year, Company Profile and etc.)

    • Table Hetero Drugs(IN) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hetero Drugs(IN) Escitalopram Product and Service

    • Table Apotex(CA) (Foundation Year, Company Profile and etc.)

    • Table Apotex(CA) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotex(CA) Escitalopram Product and Service

    • Table Jubilant Pharma(SG) (Foundation Year, Company Profile and etc.)

    • Table Jubilant Pharma(SG) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jubilant Pharma(SG) Escitalopram Product and Service

    • Table HLundbeck A/S(DK) (Foundation Year, Company Profile and etc.)

    • Table HLundbeck A/S(DK) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table HLundbeck A/S(DK) Escitalopram Product and Service

    • Table Silarx Pharmacueticals(US) (Foundation Year, Company Profile and etc.)

    • Table Silarx Pharmacueticals(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table Silarx Pharmacueticals(US) Escitalopram Product and Service

    • Table Prinston Pharmaceutical(US) (Foundation Year, Company Profile and etc.)

    • Table Prinston Pharmaceutical(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prinston Pharmaceutical(US) Escitalopram Product and Service

    • Table TEVA Pharmaceutical(US) (Foundation Year, Company Profile and etc.)

    • Table TEVA Pharmaceutical(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table TEVA Pharmaceutical(US) Escitalopram Product and Service

    • Table Hikma Pharmaceuticals(UK) (Foundation Year, Company Profile and etc.)

    • Table Hikma Pharmaceuticals(UK) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hikma Pharmaceuticals(UK) Escitalopram Product and Service

    • Table Forest Laboratories(US) (Foundation Year, Company Profile and etc.)

    • Table Forest Laboratories(US) Escitalopram Sales, Price, Value and Gross Profit (2017-2022)

    • Table Forest Laboratories(US) Escitalopram Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US